Lutz Müller (Lutz Mueller)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Capillary Electrophoresis

Placebo Controlled

Top Venues

Advances in respiratory medicine

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Olga Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Müller, Aartjan J W Te Velthuis, Victor Margitich, Andrew Goy
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial. Advances in respiratory medicine 92 (3) (2024)
Olga Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Müller, Aartjan J W Te Velthuis, Victor Margitich, Andrew Goy
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial. Advances in respiratory medicine 92 (3) (2024)
Olga Holubovska, Pavlo Babich, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Lutz Müller, Aartjan J W Te Velthuis, Victor Margitich, Andrew Goy
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial. Advances in respiratory medicine 92 (3) (2024)
Stefano Elli, Denisa Bojkova, Marco Bechtel, Thomas Vial, David Boltz, Miguel Muzzio, Xinjian Peng, Federico Sala, Cesare Cosentino, Andrew Goy, Marco Guerrini, Lutz Müller, Jindrich Cinatl, Victor Margitich, Aartjan J W Te Velthuis
Enisamium Inhibits SARS-CoV-2 RNA Synthesis. Biomedicines 9 (9) (2021)
Aartjan J W Te Velthuis, Tatiana G Zubkova, Megan Shaw, Andrew Mehle, David Boltz, Norbert Gmeinwieser, Holger Stammer, Jens Milde, Lutz Müller, Victor Margitich
Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity. Antimicrobial agents and chemotherapy 65 (4) (2021)